AAV5 Antikörper
-
- Target Alle AAV5 Produkte
- AAV5 (Adeno-Associated Virus 5 (AAV5))
- Reaktivität
- Adeno-Associated Virus 5 (AAV-5)
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser AAV5 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Immunogen
- AAV5 antibody was raised in rabbit using AAV-5 capsid proteins as the immunogen.
-
-
- Applikationshinweise
- WB: 1:300-1000, IHC: 1:50-1:100, IF: 1:100-1:500, ELISA: 1:5000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- liquid form, dilute with PBS before use
- Handhabung
- Avoid repeated freeze/thaw cycles
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy." in: Molecular therapy. Methods & clinical development, Vol. 13, pp. 440-452, (2019) (PubMed).
: "Strategy to detect pre-existing immunity to AAV gene therapy." in: Gene therapy, Vol. 24, Issue 12, pp. 768-778, (2018) (PubMed).
: "
-
The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy." in: Molecular therapy. Methods & clinical development, Vol. 13, pp. 440-452, (2019) (PubMed).
-
- Target
- AAV5 (Adeno-Associated Virus 5 (AAV5))
- Andere Bezeichnung
- AAV 5 (AAV5 Produkte)
- Substanzklasse
- Virus
-